Alfredo Cesario

Dr. Alfredo Cesario

Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS
orcid
CEO @ Gemelli Digital Medicine & Health; Digital Health Mana...

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
PBPhilippe Jean Bousquet
Philippe Jean Bousquet
HSH.J. Schünemann
H.J. Schünemann
BSB. Samolinski
B. Samolinski
PDPascal Demoly
Pascal Demoly
CBC.E. Baena-Cagnani
C.E. Baena-Cagnani
TZT. Zuberbier
T. Zuberbier

1 May 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
AFAlessandra Frustaci
Alessandra Frustaci
MNMonica Neri
Monica Neri
Alfredo CesarioAlfredo Cesario
Alfredo Cesario
JAJames B. Adams
James B. Adams
Enrico DomeniciEnrico Domenici
Enrico Domenici
Stefano BonassiStefano Bonassi
Stefano Bonassi

1 January 2011 in Genome Medicine
Verified
Journal Article
Open access
PDF file
PBPhilippe Jean Bousquet
Philippe Jean Bousquet
JAJosep M Anto
Josep M Anto
PSPeter J Sterk
Peter J Sterk
IAIan Adcock
Ian Adcock
KCKian Chung
Kian Chung
CACharles Auffray
Charles Auffray
We propose an innovative, integrated, cost-effective health system to combat major non-communicable diseases (NCDs), including cardiovascular, chronic respiratory, metabolic, rheumatologic and neurologic disorders and cancers, which together are the predominant health problem of the 21st century. This proposed holistic strategy involves comprehensive patient-centered integrated care and multi-scale, multi-modal and multi-level systems approaches to tackle NCDs as a common group of diseases. Rather than studying each disease individually, it will take into account their intertwined gene-environment, socio-economic interactions and co-morbidities that lead to individual-specific complex phenotypes. It will implement a road map for predictive, preventive, personalized and participatory (P4) medicine based on a robust and extensive knowledge management infrastructure that contains individual patient information. It will be supported by strategic partnerships involving all stakeholders, including general practitioners associated with patient-centered care. This systems medicine strategy, which will take a holistic approach to disease, is designed to allow the results to be used globally, taking into account the needs and specificities of local economies and health systems.

1 January 2002 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
LTLucio Trodella
Lucio Trodella
PGPierluigi Granone
Pierluigi Granone
SVSalvatore Valente
Salvatore Valente
VVVincenzo Valentini
Vincenzo Valentini
MBMario Balducci
Mario Balducci
NCNuma Cellini
Numa Cellini

1 August 2007 in Lung Cancer
Verified
Journal Article
Closed access
Alfredo CesarioAlfredo Cesario
Alfredo Cesario
LFLuigi Ferri
Luigi Ferri
DGDomenico Galetta
Domenico Galetta
FPFranco Pasqua
Franco Pasqua
Stefano BonassiStefano Bonassi
Stefano Bonassi
PGPierluigi Granone
Pierluigi Granone

12 June 2014 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
JBJ. Bousquet
J. Bousquet
AAAntonio Addis
Antonio Addis
IAIan Adcock
Ian Adcock
IAI. Agache
I. Agache
AAAlvar Agustí
Alvar Agustí
Torsten ZuberbierTorsten Zuberbier
Torsten Zuberbier
The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions. AIRWAYS-ICPs has strategic relevance to the European Union Health Strategy and will add value to existing public health knowledge by: 1) proposing a common framework of care pathways for chronic respiratory diseases, which will facilitate comparability and trans-national initiatives; 2) informing cost-effective policy development, strengthening in particular those on smoking and environmental exposure; 3) aiding risk stratification in chronic disease patients, using a common strategy; 4) having a significant impact on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long-term (healthy ageing); 5) proposing a common simulation tool to assist physicians; and 6) ultimately reducing the healthcare burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life. In the longer term, the incidence of disease may be reduced by innovative prevention strategies. AIRWAYSICPs was initiated by Area 5 of the Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing. All stakeholders are involved (health and social care, patients, and policy makers).